NM_194454.3:c.146_147delGA
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_194454.3(KRIT1):c.146_147delGA(p.Arg49LysfsTer14) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000031 in 1,611,308 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_194454.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- cerebral cavernous malformation 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- famililal cerebral cavernous malformationsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KRIT1 | NM_194454.3 | c.146_147delGA | p.Arg49LysfsTer14 | frameshift_variant | Exon 5 of 19 | ENST00000394505.7 | NP_919436.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KRIT1 | ENST00000394505.7 | c.146_147delGA | p.Arg49LysfsTer14 | frameshift_variant | Exon 5 of 19 | 1 | NM_194454.3 | ENSP00000378013.2 | ||
| ENSG00000289027 | ENST00000692281.1 | c.146_147delGA | p.Arg49LysfsTer14 | frameshift_variant | Exon 5 of 26 | ENSP00000510568.1 | ||||
| ENSG00000285953 | ENST00000458493.6 | c.146_147delGA | p.Arg49LysfsTer14 | frameshift_variant | Exon 4 of 20 | 4 | ENSP00000396352.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152240Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250792 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459068Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 726108 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74382 show subpopulations
ClinVar
Submissions by phenotype
Cerebral cavernous malformation Pathogenic:4
A KRIT1 c.146_147del (p.Arg49Lysfs*14) variant was identified at a near heterozygous allelic fraction of 44.4%, a frequency which may be consistent with it being of germline origin. This variant causes a frameshift by deleting two nucleotides, leading to a premature termination codon, which is predicted to lead to nonsense-mediated decay. This variant has been reported in one individual affected with cerebral cavernous malformation (Posey et al., PMID: 27959697). Other frameshift variants at the same codon c.143dup (p.Arg49Glufs*15) (Cavé-Riant F et al., PMID: 12404106; Spiegler S et al., PMID: 24689081), that also result in premature termination codons, have been identified in individuals affected with cerebral cavernous malformations. While pathogenic variants in the KRIT1 gene are typically identified in individuals with cerebral cavernous malformation, they have also been identified in individuals with cutaneous vascular malformations only, namely, hyperkeratotic cutaneous capillary-venous malformation (HCCVM) (Matarneh B et al., PMID: 34964173) as well as in multiple asymptomatic individuals (Ricci C et al., PMID: 33651268). The KRIT1 c.146_147del (p.Arg49Lysfs*14) variant is only observed on 5/1,611,308 alleles in the general population (gnomAD v.4.1.0), indicating it is not a common variant. It has been reported in the ClinVar database as a germline pathogenic variant by two submitters and a likely pathogenic variant by two submitters (ClinVar ID: 374400). Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the KRIT1 c.146_147del (p.Arg49Lysfs*14) variant is classified as pathogenic.
This sequence change creates a premature translational stop signal (p.Arg49Lysfs*14) in the KRIT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KRIT1 are known to be pathogenic (PMID: 10508515, 11222804, 12404106, 24689081). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with KRIT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 374400). For these reasons, this variant has been classified as Pathogenic.
Our laboratory reported two molecular diagnoses in COL11A1 (NM_080630.2:c.2754+5G>A) and KRIT1 (NM_194456.1:c.146_147del) in an individual with hearing loss, tics, dysmorphic features, macrocephaly, vision loss, chronic otitis media, reactive airway disease, food allergy, urticaria, eczema, and keratosis pilaris.
KRIT1-related disorder Pathogenic:1
The KRIT1 c.146_147delGA variant is predicted to result in a frameshift and premature protein termination (p.Arg49Lysfs*14). This variant has been reported to be causative for cerebral cavernous malformations (Posey et al. 2017. PubMed ID: 27959697). At PreventionGenetics, we have observed this variant in several, apparently unrelated, affected individuals. This variant is reported in 0.0018% of alleles in individuals of European (non-Finnish) descent in gnomAD. Frameshift variants in KRIT1 are expected to be pathogenic. This variant is interpreted as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at